title: A pseudo-full mutation identified in fragile X assay reveals a novel base change abolishing an EcoRI restriction site.
abstract: Diagnostic testing for the fragile X syndrome is designed to detect the most common mutation, a CGG expansion in the 5'-untranslated region of the fragile X mental retardation (FMRI) gene. PCR can determine the number of CGG repeats less than 100, whereas Southern analysis can detect large premutations, full mutations, and their methylation status. Bands larger than 5.8 kb observed via Southern analysis are usually considered a methylated full mutation, causing fragile X syndrome in males and varied clinical presentations in females. We observed a 10.9-kb band on a Southern blot assay from an autistic girl with language delay. Further investigation identified a novel G-to-A transition at an EcoRI cleavage site, upstream of the CGG repeat region of the FMRI gene. This base change abolished the EcoRI restriction site, resulting in a 10.9-kb pseudo-full mutation. This G-to-A base change has not been previously reported and was not identified in a subsequent analysis of 105 male and 30 female patient samples. The clear 10.9-kb band detected on a Southern blot assay for fragile X syndrome mimics a large, methylated full mutation, which could result in a misdiagnosis without the benefit of family studies and further testing.
authors.affiliation: Department of Genetic Testing, Kaiser Permanente, 4580 Electronics Place, Los Angeles, CA 90039-1008, USA.
authors.forename: Shujian
authors.initials: S
authors.lastname: Liang
authors.forename: Harold N
authors.initials: HN
authors.lastname: Bass
authors.forename: Hanlin
authors.initials: H
authors.lastname: Gao
authors.forename: Caroline
authors.initials: C
authors.lastname: Astbury
authors.forename: Mehdi R
authors.initials: MR
authors.lastname: Jamehdor
authors.forename: Yong
authors.initials: Y
authors.lastname: Qu
mesh_terms: D000241:Adenosine / Q000235:genetics*; D001483:Base Sequence; D015139:Blotting, Southern; D002675:Child, Preschool; D004252:DNA Mutational Analysis; D015280:DNA Restriction-Modification Enzymes / Q000235:genetics*; D005260:Female; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics; D005600:Fragile X Syndrome / Q000175:diagnosis* / Q000235:genetics*; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D016133:Polymerase Chain Reaction; D012689:Sequence Homology, Nucleic Acid; D019680:Trinucleotide Repeat Expansion / Q000235:genetics
chemical_list: D000241:Adenosine; D015280:DNA Restriction-Modification Enzymes; D051860:Fragile X Messenger Ribonucleoprotein 1